Table 5.
Interventions performed and number of eyes requiring topical hypotensive agents at the final visit
| Non PACG (n:41) | PACG (n:7) | |
|---|---|---|
| LPI | 41 (100 %) | 7 (100 %) |
| Repeat LPI | 7 (17 %) | 3 (43 %) |
| ALPI | 5 (12 %) | 1 (14 %) |
| Cyclodiode | 1 (2 %) | 0 (0 %) |
| Cataract extraction +/− GSL | 20 (49 %) | 6 (86 %) |
| Trabeculectomy + MMC | 1 (2 %) | 1 (14 %) |
| Topical hypotensive agents | 5 (12 %) | 4 (57 %) |
PACG primary angle closure glaucoma, LPI laser peripheral iridotomy, ALPI argon laser peripheral iridoplasty, GSL goniosynechialysis, MMC Mitomycin C